mRNA Therapeutics

Fast-to-Market Strategies

By:

Sarfaraz K Niazi

Format:

Hardback

Show Hide Adult Content

$395.00

Available from supplier

Usually ships in 3-4 weeks

0 in Trolley

Price Match

Free Delivery with Primate

Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $98.75 with Afterpay Learn more

6 weekly interest-free payments of $65.83 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

Around 14-26 June using International Courier

Description

This book is the most comprehensive and complete treatise on nucleic acid therapeutic products, including mRNA vaccines, their manufacturing, formulations, and testing for safety and efficacy. Details include cGMP-compliant manufacturing and regulatory filing steps. A new concept of “biosimilar” mRNA vaccine is presented to secure fast approval of copies of mRNA vaccines. Projections of financial plans to establish RNA manufacturing facilities are provided, along with details of supply chain management. Finally, the future of nucleic acid products in gene therapy and other newer applications is presented, along with a perspective that all new vaccines will be the nucleic acid type that will further provide first-time prevention of autoimmune disorders. It is projected that both big pharma and start-ups will enter this field, and we can expect significant additions to our drug armamentarium soon.

Author Biography:

Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and the University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals, and treatment of autoimmune diseases. He has hands-on experience establishing biotechnology projects, from concept to market, including FDA approvals. In addition, he has first-hand experience in establishing RNA therapeutic product development and manufacturing, including the mRNA vaccine for COVID-19. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, and many heads of state. He is also a patent law practitioner. Email: niazi@niazi.com

Release date NZ

December 6th, 2022

Author

Sarfaraz K Niazi

Audiences

Professional & Vocational
Tertiary Education (US: College)

Illustrations

44 Tables, black and white; 15 Line drawings, color; 2 Line drawings, black and white; 55 Halftones, color; 1 Halftones, black and white; 73 Illustrations, black and white

Pages

304

ISBN-13

9781032163444

Product ID

35841204

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here